Literature DB >> 16045692

Muscarinic cholinergic receptors in the human melanoma cell line SK-Mel 28: modulation of chemotaxis.

A Boss1, M Oppitz, G Lippert, U Drews.   

Abstract

Primary and metastatic human melanomas express muscarinic receptors. In embryonic tissues, expression of muscarinic receptors is correlated with morphogenesis. The hypothesis has been put forward that muscarinic receptors are involved in morphogenetic movements in the embryo, and in cellular movements in melanoma cells during invasive growth. The purpose of the present study was to characterize the muscarinic receptors in the human melanoma cell line SK-Mel 28 and to test in a Boyden chamber assay whether the chemotactic activity towards fibronectin can be influenced by muscarinic stimulation. In Western blots with the monoclonal antibody M35, muscarinic receptors were localized in a strong band at 66 kDa, and in a weak band at 63 kDa. Western blot with M3 subtype specific antibodies reproduced the line at 66 kDa. RT-PCR revealed mRNA for subtypes M3 and M5. These findings suggest that SK-Mel 28 cells express a large number of subtype M3 and a small number of subtype M5 receptors. Microscopic observation of calcium mobilization after muscarinic stimulation indicated that all cells carried functional muscarinic receptors. A standardized chemotaxis assay was established in modified Boyden chambers using fibronectin as chemotactic agent. After addition of carbachol to the upper compartment, an increase of fibronectin induced chemotaxis of approximately 30% was observed, an effect abrogated by atropine. These results demonstrate that muscarinic cholinergic treatment has a modulatory effect on fibronectin-induced chemotaxis in SK-Mel 28 melanoma cells, indicating that the muscarinic system is involved in regulation of cell movement.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16045692     DOI: 10.1111/j.1365-2230.2005.01865.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  13 in total

Review 1.  Muscarinic receptors and ligands in cancer.

Authors:  Nirish Shah; Sandeep Khurana; Kunrong Cheng; Jean-Pierre Raufman
Journal:  Am J Physiol Cell Physiol       Date:  2008-11-26       Impact factor: 4.249

2.  Acetylcholine induces mesenchymal stem cell migration via Ca2+ /PKC/ERK1/2 signal pathway.

Authors:  Jun-Ming Tang; Jie Yuan; Qing Li; Jia-Ning Wang; Xia Kong; Fei Zheng; Lei Zhang; Long Chen; Lin-Yun Guo; Yong-Hang Huang; Jian-Ye Yang; Shi-You Chen
Journal:  J Cell Biochem       Date:  2012-08       Impact factor: 4.429

3.  High expression of M3 muscarinic acetylcholine receptor is a novel biomarker of poor prognostic in patients with non-small cell lung cancer.

Authors:  Jun Wu; Jinxu Zhou; Lei Yao; Yaoguo Lang; Yingnan Liang; Lantao Chen; Jinfeng Zhang; Fengjiao Wang; Yanbo Wang; He Chen; Jianqun Ma
Journal:  Tumour Biol       Date:  2013-07-10

Review 4.  Muscarinic receptor agonists and antagonists: effects on cancer.

Authors:  Eliot R Spindel
Journal:  Handb Exp Pharmacol       Date:  2012

Review 5.  New pharmacological approaches to the cholinergic system: an overview on muscarinic receptor ligands and cholinesterase inhibitors.

Authors:  Nigel H Greig; Marcella Reale; Ada M Tata
Journal:  Recent Pat CNS Drug Discov       Date:  2013-08

6.  Cholinergic Machinery as Relevant Target in Acute Lymphoblastic T Leukemia.

Authors:  Oxana Dobrovinskaya; Georgina Valencia-Cruz; Luis Castro-Sánchez; Edgar O Bonales-Alatorre; Liliana Liñan-Rico; Igor Pottosin
Journal:  Front Pharmacol       Date:  2016-08-31       Impact factor: 5.810

7.  Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation.

Authors:  Rodrigo R Resende; Avishek Adhikari
Journal:  Cell Commun Signal       Date:  2009-08-27       Impact factor: 5.712

8.  M2muscarinic receptors inhibit cell proliferation and migration in urothelial bladder cancer cells.

Authors:  Luca Pacini; Elena De Falco; Maria Di Bari; Andrea Coccia; Camilla Siciliano; Donatella Ponti; Antonio Luigi Pastore; Vincenzo Petrozza; Antonio Carbone; Ada Maria Tata; Antonella Calogero
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

9.  M2 receptor activation inhibits cell cycle progression and survival in human glioblastoma cells.

Authors:  Michela Ferretti; Cinzia Fabbiano; Maria Di Bari; Claudia Conte; Emilia Castigli; Miriam Sciaccaluga; Donatella Ponti; Paola Ruggieri; Antonino Raco; Ruggero Ricordy; Antonella Calogero; Ada Maria Tata
Journal:  J Cell Mol Med       Date:  2013-03-14       Impact factor: 5.310

10.  Divergent effects of muscarinic receptor subtype gene ablation on murine colon tumorigenesis reveals association of M3R and zinc finger protein 277 expression in colon neoplasia.

Authors:  Kunrong Cheng; Guofeng Xie; Sandeep Khurana; Jonathon Heath; Cinthia B Drachenberg; Jennifer Timmons; Nirish Shah; Jean-Pierre Raufman
Journal:  Mol Cancer       Date:  2014-04-03       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.